{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:37:11Z","timestamp":1792499831079,"version":"4.5.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"\n Background and aims<\/jats:title>\n \n Carbapenem-resistant\n Acinetobacter baumannii<\/jats:italic>\n (CRAB) has become a leading cause of nosocomial infections with an increasing impact on critically ill patients, yet there is limited data on contributing factors. This study was aim to evaluate the prevalence and risk factors, and clinical outcomes of CRAB infections among critically ill children in a tertiary university teaching hospital in China.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n From January 2016 to December 2021, all children diagnosed with nosocomial\n Acinetobacter baumannii<\/jats:italic>\n (\n A. baumannii<\/jats:italic>\n ) infections in the pediatric intensive care unit (PICU) were identified through the computerized microbiology laboratory databases. Among them, children suffering from CRAB infection were designated as a case group, while children with carbapenem susceptible\n A. baumannii<\/jats:italic>\n (CSAB) infection were assigned to a control group. This retrospective case-control study was based on two groups of patients to determine potential clinical factors contributing to CRAB infection and death among critically ill children via univariate and multivariate analyses.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n During the 6-year study period, a total of 372 episodes of nosocomial\n A. baumannii<\/jats:italic>\n infection in the PICU were eligible and included in the study. These isolates displayed moderate or high rates of resistance to all tested antimicrobials except colistin. The overall prevalence of CRAB and MDRAB (multidrug-resistant\n A. baumannii<\/jats:italic>\n ) was 78.0% and 80.9%, respectively. Several risk factors found to significantly increase CRAB infection included receiving invasive operation (OR = 9.412,\n p<\/jats:italic>\n = 0.001), gastric intubation (OR = 2.478,\n p<\/jats:italic>\n = 0.026), prior carbapenems exposure (OR = 2.543,\n p<\/jats:italic>\n = 0.003), severe pneumonia (OR = 3.235,\n p<\/jats:italic>\n = 0.001), and hemoglobin &lt;110g\/L (OR = 3.049,\n p<\/jats:italic>\n = 0.005). Of 372 patients with CRAB infection, the mortality rate was 30.9% (115\/372) and mortality did not differ between children with CRAB and CSAB infections. Septic shock (OR = 2.992,\n p<\/jats:italic>\n = 0.001), AST &gt; 46U\/L (OR = 2.015,\n p<\/jats:italic>\n = 0.005), bone marrow aspiration (OR = 2.704,\n p<\/jats:italic>\n = 0.008), lymphocyte &lt;20 % (OR = 1.992,\n p<\/jats:italic>\n = 0.006) and age (OR = 1.094,\n p<\/jats:italic>\n = 0.002) were independent risk factors for the death of\n A. baumanni<\/jats:italic>\n infection.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n \n This study highlights considerable incidence rate and remarkable mortality of children with\n A. baumanni<\/jats:italic>\n (especially CRAB) infections, and identifies age-specific risk factors for CRAB infection and mortality in critically ill children. These risk factors should be taken into account in pediatric hospitals in order to establish early intervention and rational treatment to improve clinical outcomes.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fpubh.2023.1282413","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T04:39:41Z","timestamp":1701405581000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Insights into the epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Acinetobacter baumannii infections in critically ill children"],"prefix":"10.3389","volume":"11","author":[{"given":"Yufei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1469-0691.2005.01227.x","article-title":"Clinical impact and pathogenicity of Acinetobacter","volume":"11","author":"Joly-Guillou","year":"2005","journal-title":"Clin Microbiol Infect."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1056\/NEJMra070741","article-title":"Acinetobacter infection","volume":"358","author":"Munoz-Price","year":"2008","journal-title":"N Engl J Med."},{"key":"B3","first-page":"1009","article-title":"Acinetobacter infections: a growing threat for critically ill patients","volume-title":"Epidemiol Infect.","author":"Falagas","year":"2008"},{"key":"B4","first-page":"191","article-title":"Acinetobacter infections prevalence and frequency of the antibiotics resistance: comparative study of intensive care units versus other hospital units","volume-title":"Pan Afr Med J.","author":"Uwingabiye","year":"2016"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0028321","DOI":"10.1128\/Spectrum.00283-21","article-title":"Bacterial epidemiology and antimicrobial resistance profiles in children reported by the ISPED program in China, 2016 to 2020","volume":"9","author":"Fu","year":"2021","journal-title":"Microbiol Spectr."},{"key":"B6","unstructured":"Surveillance of Antimicrobial Resistance in Europe. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)2020"},{"key":"B7","unstructured":"Antibiotic Resistant Threats in the United States 20192019"},{"key":"B8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/CMR.00058-07","article-title":"Acinetobacter baumannii: emergence of a successful pathogen","volume":"21","author":"Peleg","year":"2008","journal-title":"Clin Microbiol Rev."},{"key":"B9","unstructured":"2023"},{"key":"B10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/jpids\/piy018","article-title":"Acinetobacter baumannii resistance trends in children in the United States, 1999-2012","volume":"8","author":"Logan","year":"2019","journal-title":"J Pediatric Infect Dis Soc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1089\/mdr.2018.0465","article-title":"Risk factors for mortality in children with acinetobacter baumannii bacteremia in South Korea: the role of carbapenem resistance","volume":"25","author":"Choe","year":"2019","journal-title":"Microb Drug Resist."},{"key":"B12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jmii.2017.07.013","article-title":"Risk factors and molecular epidemiology of Acinetobacter baumannii bacteremia in neonates","volume":"51","author":"Lee","year":"2018","journal-title":"J Microbiol Immunol Infect."},{"key":"B13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jiac.2016.03.013","article-title":"Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia in the neonate: A case-case-control study","volume":"22","author":"Thatrimontrichai","year":"2016","journal-title":"J Infect Chemother."},{"key":"B14","first-page":"61","article-title":"Diagnostic criteria for nosocomial infection (for trial implementation)","volume":"5","year":"2001","journal-title":"Natl Med J China"},{"key":"B15","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing.","year":"2021"},{"key":"B16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"B17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ijantimicag.2008.02.013","article-title":"Acinetobacter baumannii: a universal threat to public health?","volume":"32","author":"Giamarellou","year":"2008","journal-title":"Int J Antimicrob Agents."},{"key":"B18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13756-021-00909-8","article-title":"The epidemiology of carbapenem resistance in Acinetobacter baumannii complex in Germany (2014-2018): an analysis of data from the national Antimicrobial Resistance Surveillance system","volume":"10","author":"Said","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"key":"B19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13756-020-00750-5","article-title":"The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017","volume":"9","author":"Ayobami","year":"2020","journal-title":"Antimicrob Resist Infect Control."},{"key":"B20","doi-asserted-by":"publisher","first-page":"115557","DOI":"10.1016\/j.diagmicrobio.2021.115557","article-title":"Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020)","volume":"102","author":"Sader","year":"2022","journal-title":"Diagn Microbiol Infect Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3390\/molecules24101849","article-title":"Biofilm formation in Acinetobacter Baumannii: genotype-phenotype correlation","volume":"24","author":"Yang","year":"2019","journal-title":"Molecules."},{"key":"B22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ijid.2014.01.018","article-title":"Prior use of four invasive procedures increases the risk of Acinetobacter baumannii nosocomial bacteremia among patients in intensive care units: a systematic review and meta-analysis","volume":"22","author":"Zhou","year":"2014","journal-title":"Int J Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1099\/jmm.0.001222","article-title":"Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in Acinetobacter baumannii complex bacteraemia: experience from the Chinese Antimicrobial Resistance Surveillance of Nosocomial Infections (CARES) Network","volume":"69","author":"Liu","year":"2020","journal-title":"J Med Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3346\/jkms.2012.27.8.939","article-title":"Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care unit","volume":"27","author":"Kim","year":"2012","journal-title":"J Korean Med Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jecm.2014.06.003","article-title":"Risk factors of carbapenem-resistant Acinetobacter baumannii Infection among Hospitalized Patients","volume":"6","author":"Chen","year":"2014","journal-title":"J Exp Clin Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.18295\/squmj.2018.18.01.012","article-title":"Identifying risk factors for healthcare-associated infections caused by carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit","volume":"18","author":"Sultan","year":"2018","journal-title":"Sultan Qaboos Univ Med J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1128\/AAC.48.3.1070.2004","article-title":"Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study","volume":"48","author":"Lee","year":"2004","journal-title":"Antimicrob Agents Chemother."},{"key":"B28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/pathogens10030373","article-title":"Acinetobacter baumannii antibiotic resistance mechanisms","volume":"10","author":"Kyriakidis","year":"2021","journal-title":"Pathogens."},{"key":"B29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.37201\/req\/061.2021","article-title":"Association between antibiotic pressure and the risk of colonization\/infection by multidrug-resistant Acinetobacter baumannii complex: a time series analysis","volume":"34","author":"Huertas Vaquero","year":"2021","journal-title":"Rev Esp Quimioter."},{"key":"B30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0305-4179(02)00012-8","article-title":"Multi-resistant Acinetobacter baumannii on a burns unit\u2013clinical risk factors and prognosis","volume":"28","author":"Wong","year":"2002","journal-title":"Burns."},{"key":"B31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0195-6701(03)00046-X","article-title":"Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment","volume":"54","author":"Smolyakov","year":"2003","journal-title":"J Hosp Infect."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1051364","DOI":"10.3389\/fmicb.2022.1051364","article-title":"Microbiological characteristics and risk factors on prognosis associated with Acinetobacter baumannii bacteremia in general hospital: a single-center retrospective study","volume":"13","author":"Wei","year":"2022","journal-title":"Front Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e764","DOI":"10.1016\/j.ijid.2010.02.2254","article-title":"A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii","volume":"14","author":"Sheng","year":"2010","journal-title":"Int J Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"6270","DOI":"10.1128\/AAC.01520-13","article-title":"Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes","volume":"57","author":"Chopra","year":"2013","journal-title":"Antimicrob Agents Chemother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4844","DOI":"10.1128\/AAC.01728-10","article-title":"Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections","volume":"55","author":"Esterly","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jinf.2019.05.017","article-title":"Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: clinical features, therapy and outcome from a multicenter study","volume":"79","author":"Russo","year":"2019","journal-title":"J Infect."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/S0195-5616(89)50137-2","article-title":"Septic shock","volume":"19","author":"Goodwin","year":"1989","journal-title":"Vet Clin North Am Small Anim Pract."},{"key":"B38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00134-007-0934-2","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008","volume":"34","author":"Dellinger","year":"2008","journal-title":"Intensive Care Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3748\/wjg.v21.i3.711","article-title":"Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine","volume":"21","author":"Sookoian","year":"2015","journal-title":"World J Gastroenterol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"S364","DOI":"10.1016\/j.jaci.2007.06.016","volume":"121","author":"Larosa","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"672050","DOI":"10.3389\/frai.2021.672050","article-title":"Reliable and interpretable mortality prediction with strong foresight in COVID-19 patients: an international study from China and Germany","volume":"4","author":"Bai","year":"2021","journal-title":"Front Artif Intell"},{"key":"B42","first-page":"1086","article-title":"Acinetobacter baumannii infection-related mortality in hospitalized patients: risk factors and potential targets for clinical and antimicrobial stewardship interventions","volume-title":"Antibiotics (Basel).","author":"Alrahmany","year":"2022"},{"key":"B43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00256-021-03882-w","article-title":"Bone marrow aspiration and biopsy: techniques and practice implications","volume":"51","author":"Tomasian","year":"2022","journal-title":"Skeletal Radiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/bjh.15630","article-title":"A rare complication of bone marrow aspiration and trephine biopsy: Staphylococcus aureus osteomyelitis and septicaemia","volume":"184","author":"Khakwani","year":"2019","journal-title":"Br J Haematol."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1282413\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T04:39:50Z","timestamp":1701405590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1282413\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":44,"alternative-id":["10.3389\/fpubh.2023.1282413"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1282413","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"article-number":"1282413"}}